Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette-Guérin instillation therapy of patients with carcinoma in situ of the bladder: a subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up.
Riikka JärvinenEero KaasinenErkki RintalaThe Finnbladder GroupPublished in: Scandinavian journal of urology and nephrology (2012)
The long-term bladder cancer-specific mortality was unexpectedly low despite the relatively ineffective instillation therapy and the poor outcome of the patients after progression.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- spinal cord injury
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- clinical trial
- risk factors
- stem cells
- cardiovascular disease
- bone marrow
- muscle invasive bladder cancer
- cell therapy
- mesenchymal stem cells
- phase iii